CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS FOR STAKEHOLDERS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK

3.4.1. U.S. FDA
3.4.2. Europe CE Mark
3.4.3. Ministry of Health, Labor and Welfare (MHLW)

3.5. TOP PLAYER POSITIONING, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Growth in geriatric population and rise in mitral valve disorders
3.6.1.2. Technological advancements and introduction of novel mitral valves
3.6.1.3. Shorter recovery time and less duration of stay in the hospital

3.6.2. Restraints

3.6.2.1. Stringent regulations by the governing bodies
3.6.2.2. High cost of mitral valve surgeries and risks associated with this procedure

3.6.3. Opportunities

3.6.3.1. Rise in healthcare expenditure and emergence of cardiovascular diseases in developing countries

CHAPTER 4 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MECHANICAL VALVES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. MITRAL VALVE STENOSIS

5.2.1. Market size and forecast

5.3. MITRAL VALVE PROLAPSE

5.3.1. Market size and forecast

5.4. MITRAL VALVE REGURGITATION

5.4.1. Market size and forecast

CHAPTER 6 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. North America Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Country
6.2.4. North America Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Product type
6.2.5. North America Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Indication

6.2.5.1. U.S., by product type
6.2.5.2. U.S., by indication
6.2.5.3. Canada, by product type
6.2.5.4. Canada, by indication
6.2.5.5. Mexico, by product type
6.2.5.6. Mexico, by indication

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Europe Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Country
6.3.4. Europe Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Product type
6.3.5. Europe Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Indication

6.3.5.1. Germany, by product type
6.3.5.2. Germany, by indication
6.3.5.3. France, by product type
6.3.5.4. France, by indication
6.3.5.5. UK, by product type
6.3.5.6. UK, by indication
6.3.5.7. Italy, by product type
6.3.5.8. Italy, by indication
6.3.5.9. Spain, by product type
6.3.5.10. Spain, by indication
6.3.5.11. Rest of Europe, by product type
6.3.5.12. Rest of Europe, by indication

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Asia-Pacific Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Country
6.4.4. Asia-Pacific Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Product type
6.4.5. Asia-Pacific Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Indication

6.4.5.1. Japan, by product type
6.4.5.2. Japan, by indication
6.4.5.3. China, by product type
6.4.5.4. China, by indication
6.4.5.5. Australia, by product type
6.4.5.6. Australia, by indication
6.4.5.7. India, by product type
6.4.5.8. India, by indication
6.4.5.9. Rest of Asia-Pacific, by product type
6.4.5.10. Rest of Asia-Pacific, by indication

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Country
6.5.4. LAMEA Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Product type
6.5.5. LAMEA Market Size and Forecast for Transcatheter Mitral Valve Repair & Replacement Market by Indication

6.5.5.1. Brazil, by product type
6.5.5.2. Brazil, by indication
6.5.5.3. Saudi Arabia, by product type
6.5.5.4. Saudi Arabia, by indication
6.5.5.5. South Africa, by product type
6.5.5.6. South Africa, by indication
6.5.5.7. Israel, by product type
6.5.5.8. Israel, by indication
6.5.5.9. Rest of LAMEA, by product type
6.5.5.10. Rest of LAMEA, by indication

CHAPTER 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. BIOTRONIK SE & CO. KG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio

7.3. COLIBRI HEART VALVE, LLC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments

7.4. EDWARDS LIFE SCIENCE CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. HLT, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio

7.6. LIVANOVA PLC

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. MEDTRONIC PLC

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. NEOVASC INC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. NEOCHORD INC.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio

7.10. CORAMAZE TECHNOLOGIES GMBH.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Product portfolio